Revitalist Lifestyle and Wellness Ltd.

Equities

CALM

CA76151T1030

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange 15:32:36 08/05/2023 BST 5-day change 1st Jan Change
0.02 CAD -.--% Intraday chart for Revitalist Lifestyle and Wellness Ltd. -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Revitalist Lifestyle and Wellness Ltd. Appoints Kathryn Walker as President; Announces Board and Committee Changes CI
Revitalist Lifestyle and Wellness Ltd. Announces President Changes CI
Revitalist Lifestyle and Wellness Ltd. Announces Resignation of Doran Andry as A Director CI
Revitalist Lifestyle and Wellness Ltd. Announces Change Financial Year End CI
Revitalist Lifestyle and Wellness Ltd. Announces Executive Changes CI
Revitalist Lifestyle and Wellness Ltd. announced that it has received CAD 1.1395 million in funding CI
Revitalist Lifestyle and Wellness Ltd. announced that it expects to receive CAD 1.7 million in funding CI
Revitalist Lifestyle and Wellness Appoints COO MT
Revitalist Lifestyle and Wellness Ltd. Enters into Network Agreement for Specialty Providers with Corechoice CI
Revitalist Appoints Paul Auchterlonie as Chief Operating Officer CI
Revitalist Lifestyle and Wellness Ltd. announced that it has received CAD 0.595 million in funding CI
Revitalist Lifestyle and Wellness Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Revitalist and Wake Network Announce Joint Venture Partnership to Open Psychedelic Clinics and Retreats in the United States CI
Revitalist Lifestyle and Wellness Ltd. Releases Supplement Line to Enhance the Results of Psychedelic Medicines CI
Revitalist Lifestyle and Wellness Ltd. and Wake Network, Inc. Enter Joint Venture Offering National and International Access to Psychedelics for Veterans CI
Revitalist Lifestyle and Wellness Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Revitalist Lifestyle and Wellness Ltd. announced that it has received CAD 3.944 million in funding CI
Revitalist Lifestyle and Wellness Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Revitalist Lifestyle and Wellness Ltd. Reports Sales Results for the April Month of 2022 CI
Revitalist Lifestyle and Wellness Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Revitalist Lifestyle and Wellness Ltd. Auditor Raises 'Going Concern' Doubt CI
Revitalist Lifestyle and Wellness Ltd. announced that it expects to receive CAD 6 million in funding CI
Revitalist and Pharmather Announce Collaboration to Develop and Advance Novel and Standardized Ketamine Treatment Protocols for Mental Health Disorders and Chronic Pain Syndromes CI
Revitalist Lifestyle and Wellness Ltd. Receives Approval from Biomedical Research Alliance of New York to Perform Human Subjects Clinical Trials CI
Revitalist Lifestyle and Wellness Ltd. Increases National Footprint to 60,000 Square Feet and Becomes One of the Largest Publicly Listed Ketamine Focused Treatment Chains in the U.S CI
Chart Revitalist Lifestyle and Wellness Ltd.
More charts
Revitalist Lifestyle and Wellness Ltd. is a mental health company. The Company is primarily engaged in the provision of psychotherapy services. It provides ketamine-assisted psychotherapy and other treatments through its network of integrative mental health clinics. The Company’s segments include Clinical Operations and Research. Its Clinical Operations segment encompass the Company’s ketamine assisted psychotherapy clinics across the United States of America. The Company’s Research segment consists of the development of virtual clinics in the metaverse and research focused expenses. It is a provider of patient-focused treatments via the operation of medical clinics, which guide patients through ketamine-enhanced psychotherapy. Its ketamine-enhanced psychotherapy (KEP) is a clinic-based treatment that combines the administration of ketamine with psychotherapy sessions. KEP is prescribed for depression, post-traumatic stress disorder (PTSD), and such other treatment applications.
More about the company